Tracking Baker Brothers Portfolio - Q4 2024 Update
Baker Brothers' 13F portfolio value decreased from $9.65B to $9.36B. Check out the portfolio's top holdings and notable stake ...
Denali Therapeutics (NASDAQ:DNLI) Price Target Lowered to $28.00 at Bank of America
Denali Therapeutics (NASDAQ:DNLI – Get Free Report) had its target price reduced by Bank of America from $30.00 to $28.00 in ...
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.9% After Analyst Downgrade
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) were down 8.9% during trading on Monday after Bank of America lowered their price target on the stock from $30.00 to $28.00. Bank of ...
Denali Therapeutics (DNLI) Receives a Buy from Bank of America Securities
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Denali Therapeutics (DNLI – Research Report) today. The company’s ...
Denali Therapeutics price target lowered to $28 from $30 at BofA
BofA lowered the firm’s price target on Denali Therapeutics (DNLI) to $28 from $30 and keeps a Buy rating on the shares. The firm updated for ...
American Association of Individual Investors4d
Why Denali Therapeutics Inc.’s (DNLI) Stock Is Down 10.43%
Denali Therapeutics Inc.’s DNLI share price has dipped by 10.43%, which has investors questioning if this is right time to buy.